DK0828758T3 - Kimæriske fedtlegeme-pro-GRF-analoger med forøget biologisk potensering - Google Patents
Kimæriske fedtlegeme-pro-GRF-analoger med forøget biologisk potenseringInfo
- Publication number
- DK0828758T3 DK0828758T3 DK96914826T DK96914826T DK0828758T3 DK 0828758 T3 DK0828758 T3 DK 0828758T3 DK 96914826 T DK96914826 T DK 96914826T DK 96914826 T DK96914826 T DK 96914826T DK 0828758 T3 DK0828758 T3 DK 0828758T3
- Authority
- DK
- Denmark
- Prior art keywords
- grf
- pro
- chimeric
- grf analogs
- adipose
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45306795A | 1995-05-26 | 1995-05-26 | |
US65164596A | 1996-05-22 | 1996-05-22 | |
PCT/CA1996/000327 WO1996037514A1 (en) | 1995-05-26 | 1996-05-22 | Chimeric fatty body-pro-grf analogs with increased biological potency |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0828758T3 true DK0828758T3 (da) | 2002-01-07 |
Family
ID=27036979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96914826T DK0828758T3 (da) | 1995-05-26 | 1996-05-22 | Kimæriske fedtlegeme-pro-GRF-analoger med forøget biologisk potensering |
Country Status (13)
Country | Link |
---|---|
US (2) | US5939386A (da) |
EP (1) | EP0828758B1 (da) |
JP (1) | JP3576170B2 (da) |
KR (1) | KR100543190B1 (da) |
AT (1) | ATE204881T1 (da) |
AU (1) | AU697119B2 (da) |
BR (2) | BRPI9608799B8 (da) |
CA (1) | CA2222068C (da) |
DE (1) | DE69614849T2 (da) |
DK (1) | DK0828758T3 (da) |
ES (1) | ES2163020T3 (da) |
PT (1) | PT828758E (da) |
WO (1) | WO1996037514A1 (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020311A (en) * | 1995-05-26 | 2000-02-01 | Theratechnologies, Inc. | GRF analogs with increased biological potency |
US6458764B1 (en) * | 1995-05-26 | 2002-10-01 | Theratechnologies Inc. | GRF analogs with increased biological potency |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
US6696063B1 (en) * | 1998-12-30 | 2004-02-24 | Applied Research Systems Ars Holding N.V. | Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy |
PT1141014E (pt) | 1999-01-06 | 2005-04-29 | Genentech Inc | Variante mutante do factor de crescimento semelhante a insulina (igf-i) |
EP1052286A3 (en) * | 1999-04-12 | 2001-07-25 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
US6759393B1 (en) | 1999-04-12 | 2004-07-06 | Pfizer Inc. | Growth hormone and growth hormone releasing hormone compositions |
EP1282437B1 (en) | 2000-05-16 | 2008-03-19 | Genentech, Inc. | Treatment of cartilage disorders |
WO2002010195A2 (en) * | 2000-08-02 | 2002-02-07 | Theratechnologies Inc. | Modified peptides with increased potency |
EP1205551A1 (en) * | 2000-11-09 | 2002-05-15 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
FR2851461B1 (fr) * | 2003-02-21 | 2007-04-20 | Seppic Sa | Utilisation de n-octanoyl aminoacides comme actif cosmetique et pharmaceutique amincissant |
AU2003229222B2 (en) * | 2003-05-29 | 2009-11-12 | Theratechnologies Inc. | GRF analog compositions and their use |
DK2274978T3 (da) | 2003-09-12 | 2015-06-15 | Ipsen Biopharmaceuticals Inc | Fremgangsmåder til behandling af en insulin-lignende vækstfaktor-I(IGF-I)-mangel |
AU2004281084B2 (en) * | 2003-10-20 | 2010-08-12 | Theratechnologies Inc. | Use of growth hormone releasing factor analogs in treating patients suffering from wasting |
PT2118123E (pt) | 2007-01-31 | 2016-02-10 | Harvard College | Péptidos de p53 estabilizados e suas utilizações |
WO2008121767A2 (en) | 2007-03-28 | 2008-10-09 | President And Fellows Of Harvard College | Stitched polypeptides |
EP2421547A1 (en) * | 2009-04-20 | 2012-02-29 | Theratechnologies Inc. | Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
RU2582678C2 (ru) | 2010-08-13 | 2016-04-27 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
WO2012037519A2 (en) * | 2010-09-16 | 2012-03-22 | University Of Miami | Acceleration of wound healing by growth hormone releasing hormone and its agonists |
WO2012142706A1 (en) | 2011-04-21 | 2012-10-26 | Theratechnologies Inc. | Growth hormone releasing factor (grf) analogs and uses thereof |
TWI643868B (zh) | 2011-10-18 | 2018-12-11 | 艾利倫治療公司 | 擬肽巨環化合物 |
JP6450191B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス,インコーポレイテッド | ペプチドミメティック大環状化合物 |
EP2819688A4 (en) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES |
CN102702343A (zh) * | 2012-06-14 | 2012-10-03 | 吉尔生化(上海)有限公司 | 一种固相合成替莫瑞林的方法 |
WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
WO2014071241A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
US8871713B2 (en) | 2013-03-01 | 2014-10-28 | Theratechnologies Inc. | Formulations of growth hormone releasing factor (GRF) molecules with improved stability |
KR20170058424A (ko) | 2014-09-24 | 2017-05-26 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
JP2018516844A (ja) | 2015-03-20 | 2018-06-28 | エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. | ペプチド模倣大環状分子およびその使用 |
CN109153712B (zh) | 2016-04-19 | 2022-09-16 | 格里芬制药国际公司 | Peg化生物活性肽及其用途 |
WO2024091863A1 (en) * | 2022-10-25 | 2024-05-02 | Starrock Pharma Llc | Combinatorial, and rotational combinatorial therapies for obesity and other diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4622312A (en) * | 1984-09-24 | 1986-11-11 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
CA1271600A (en) * | 1985-01-07 | 1990-07-10 | David Howard Coy | Growth hormone-releasing peptides and method of treating mammals therewith |
US4870054A (en) * | 1985-09-27 | 1989-09-26 | Recker Robert R | Treatment for osteoporosis using GRF or a biologically active analog thereof |
DE3742633A1 (de) * | 1987-12-16 | 1989-06-29 | Hoechst Ag | Peptide mit beeinflussender wirkung auf die hypophyse von saeugern |
IL86102A (en) * | 1987-05-11 | 1994-04-12 | Univ Tulane | Alkylated peptides that release growth hormone and their use |
FR2622455B1 (fr) * | 1987-11-04 | 1991-07-12 | Agronomique Inst Nat Rech | Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes |
US5065748A (en) * | 1989-11-14 | 1991-11-19 | University Of South Florida | Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone |
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
ZA922746B (en) * | 1991-04-26 | 1992-12-30 | Lilly Co Eli | Superactive grf analogs |
-
1996
- 1996-05-22 BR BRPI9608799A patent/BRPI9608799B8/pt unknown
- 1996-05-22 AU AU56833/96A patent/AU697119B2/en not_active Expired
- 1996-05-22 JP JP53522596A patent/JP3576170B2/ja not_active Expired - Lifetime
- 1996-05-22 ES ES96914826T patent/ES2163020T3/es not_active Expired - Lifetime
- 1996-05-22 BR BRPI9608799-4A patent/BR9608799B1/pt not_active IP Right Cessation
- 1996-05-22 AT AT96914826T patent/ATE204881T1/de active
- 1996-05-22 KR KR1019970708413A patent/KR100543190B1/ko not_active IP Right Cessation
- 1996-05-22 EP EP96914826A patent/EP0828758B1/en not_active Expired - Lifetime
- 1996-05-22 DE DE69614849T patent/DE69614849T2/de not_active Expired - Lifetime
- 1996-05-22 DK DK96914826T patent/DK0828758T3/da active
- 1996-05-22 WO PCT/CA1996/000327 patent/WO1996037514A1/en not_active Application Discontinuation
- 1996-05-22 PT PT96914826T patent/PT828758E/pt unknown
- 1996-05-22 CA CA002222068A patent/CA2222068C/en not_active Expired - Lifetime
- 1996-08-23 US US08/702,113 patent/US5939386A/en not_active Expired - Lifetime
- 1996-08-23 US US08/702,114 patent/US5861379A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100543190B1 (ko) | 2006-06-23 |
DE69614849T2 (de) | 2002-05-16 |
EP0828758B1 (en) | 2001-08-29 |
CA2222068C (en) | 2007-04-10 |
ES2163020T3 (es) | 2002-01-16 |
EP0828758A1 (en) | 1998-03-18 |
US5939386A (en) | 1999-08-17 |
CA2222068A1 (en) | 1996-11-28 |
BR9608799A (pt) | 1999-12-07 |
MX9709098A (es) | 1998-06-30 |
BR9608799B1 (pt) | 2009-12-01 |
BRPI9608799B8 (pt) | 2019-11-05 |
DE69614849D1 (de) | 2001-10-04 |
JPH11505807A (ja) | 1999-05-25 |
AU5683396A (en) | 1996-12-11 |
KR19990021938A (ko) | 1999-03-25 |
ATE204881T1 (de) | 2001-09-15 |
JP3576170B2 (ja) | 2004-10-13 |
AU697119B2 (en) | 1998-09-24 |
WO1996037514A1 (en) | 1996-11-28 |
US5861379A (en) | 1999-01-19 |
PT828758E (pt) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0828758T3 (da) | Kimæriske fedtlegeme-pro-GRF-analoger med forøget biologisk potensering | |
ATE311453T1 (de) | Grf-analoge mit erhöhter biologischer potenz | |
MX9204861A (es) | Analogos de polipeptidos que tienen actividad liberadora de la hormona de crecimiento. | |
ATE494902T1 (de) | Ein huhn gnrh-ii analog zur verwendung in der reduktion des tumorzellwachstums | |
ATE76296T1 (de) | Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie. | |
FR2591485B1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
RU93005051A (ru) | Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации | |
DK193887D0 (da) | Fysiologisk aktivt peptid | |
HK1006154A1 (en) | Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis | |
SE8008415L (sv) | Cyklisk analog for fagocytosstimulerande naturpeptid, dvs treonyl-cyklo-(-n-lysyl-prolyl-arginyl-) | |
GR3005612T3 (da) | ||
GR3023038T3 (en) | Use of coconut precursor fatty acid as insect-repellent. | |
ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
ES2002083A6 (es) | Un metodo para preparar derivados de piroglutamida | |
GR3014916T3 (en) | Peptide compounds having growth hormone releasing activity. | |
ES8700054A1 (es) | Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico. | |
ATE25708T1 (de) | Biologisch aktive konjugate, ihre herstellung und ihre anwendung. | |
IL85029A (en) | Microcrystalline cis diammineplatinum(ii)complex of 1,1-cyclobutanedicarboxylic acid,its preparation and cytostatic pharmaceutical compositions containing it | |
ATE39697T1 (de) | Erythromycin-a-salz mit mucosecretolytischer und fluidisierender aktivitaet, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen. | |
UA19786A (uk) | Засіб для обробки бульб кортоплі перед посадкою | |
IL78609A0 (en) | Utilizing of straw as animal feed | |
JPS57142922A (en) | Physiologically active substance and immuno-activating agent | |
ATE96336T1 (de) | Anordnung zur selbstverabreichung physiologisch aktiver substanzen unter vorbeugung einer ueberdosierung. |